2025-03-25 11:26:32
Latest Post
Godrej Properties has sold over 300 homes worth over INR 1,000 crores at Godrej Madison Avenue in Hyderabad
EaseMyTrip expands globally with Strategic Investments in Brazil, the Middle East, and the U.S
Engineers India Ltd receives contract worth Rs. 730 crores
Ola Electric arm settles dues with Rosmerta Group
Garment Mantra Lifestyle Ltd has officially launched Own Online Sales
Stock Report
Neuland Laboratories Ltd Q2 FY2025 consolidated PAT declines to Rs. 32.84 crores
Posted On : 2024-11-06 21:03:15( TIMEZONE : IST )
Neuland Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2024.
Financial Results (Q2 FY2025) - QoQ Comparison
The company has reported total income of Rs. 315.1762 crores during the period ended September 30, 2024 as compared to Rs. 444.4087 crores during the period ended June 30, 2024.
The company has posted net profit / (loss) of Rs. 32.8427 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 97.8727 crores for the period ended June 30, 2024.
The company has reported EPS of Rs. 25.60 for the period ended September 30, 2024 as compared to Rs. 76.28 for the period ended June 30, 2024.
| Financials | Q2 FY2025 | Q1 FY2025 | % Change |
| Total Income | ₹ 315.1762 crs | ₹444.4087 crs |  -29.08% |
| Net Profit | ₹32.8427 crs | ₹97.8727 crs | -66.44% |
| EPS | ₹25.60 | ₹76.28 | -66.44% |
Financial Results (Q2 FY2025) - YoY Comparison
The company has reported total income of Rs. 315.1762 crores during the period ended September 30, 2024 as compared to Rs.420.7964 crores during the period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.32.8427 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.89.2478 crores for the period ended September 30, 2023.
The company has reported EPS of Rs.25.60 for the period ended September 30, 2024 as compared to Rs.69.56 for the period ended September 30, 2023.
| Financials | Q2 FY2025 | Q2 FY2024 | % Change |
| Total Income | ₹ 315.1762 crs | ₹420.7964 crs | -25.10% |
| Net Profit | ₹32.8427 crs | ₹89.2478 crs | -63.20% |
| EPS | ₹25.60 | ₹69.56 | -63.20% |
Financial Results (Half Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.759.5849 crores during the 6 Months period ended September 30, 2024 as compared to Rs.785.8292 crores during the 6 Months period ended September 30, 2023.
The company has posted net profit / (loss) of Rs.130.7154 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.151.1268 crores for the 6 Months period ended September 30, 2023.
The company has reported EPS of Rs.101.88 for the 6 Months period ended September 30, 2024 as compared to Rs.117.79 for the 6 Months period ended September 30, 2023.
| Financials | Half Year Ended FY2025 | Half Year Ended FY2024 | % Change |
| Total Income | ₹759.5849 crs | ₹785.8292 crs | -3.34% |
| Net Profit | ₹130.7154 crs | ₹151.1268 crs | -13.51% |
| EPS | ₹101.88 | ₹117.79 | -13.51% |
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 14200.45 as compared to the previous close of Rs. 15836.60. The total number of shares traded during the day was 11646 in over 4280 trades.
The stock hit an intraday high of Rs. 16298.00 and intraday low of 13526.00. The net turnover during the day was Rs. 166501930.00.
